![Mark P. Naylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Mark P.
Naylor is a Managing Director at TransOcean Group Ltd.
Prior to joining TransOcean Group in December 2004, Mr. Naylor was a Co-Founder & Managing Director at Overture Capital Partners, a Vice President at Stolberg Partners, and an Associate at Shields & Company.
Mr. Naylor received a BS degree in Finance and Business Administration from Boston University and an MBA degree from Columbia University.
Ehemalige bekannte Positionen von Mark P. Naylor
| Unternehmen | Position | Ende |
|---|---|---|
TransOcean Group Ltd.
 TransOcean Group Ltd. Investment ManagersFinance TransOcean Group invests in companies located in the United States with an enterprise value of USD 100 - 200 million. The firm targets companies operating in the fields of industrial manufacturing, branded consumer products, healthcare services and medical devices. It provides financing for growth stage capital requirements and acquires majority interest. | Chief Investment Officer | 01.01.2014 |
Ausbildung von Mark P. Naylor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransOcean Group Ltd.
TransOcean Group Ltd. Investment ManagersFinance TransOcean Group invests in companies located in the United States with an enterprise value of USD 100 - 200 million. The firm targets companies operating in the fields of industrial manufacturing, branded consumer products, healthcare services and medical devices. It provides financing for growth stage capital requirements and acquires majority interest. | Finance |
